| FNBGX | PEDPX | FNBGX / PEDPX | |
| Total Expense Ratio | 0.03 | 6.90 | 0% |
| Annual Report Gross Expense Ratio | 0.03 | 6.90 | 0% |
| Fund Existence | 8 years | 17 years | - |
| Gain YTD | 7.212 | 7.346 | 98% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 1000000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 4.96B | 474M | 1,046% |
| Annual Yield % from dividends | 3.46 | 3.10 | 112% |
| Returns for 1 year | 2.41 | -0.95 | -253% |
| Returns for 3 years | 2.43 | -9.16 | -27% |
| Returns for 5 years | -33.01 | -64.53 | 51% |
| Returns for 10 years | N/A | -47.51 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| NESGX | 19.93 | 0.24 | +1.22% |
| Needham Small Cap Growth Retail | |||
| VCRIX | 15.08 | 0.08 | +0.53% |
| NYLI CBRE Global Infrastructure Class I | |||
| MSCDX | 19.28 | 0.08 | +0.42% |
| MassMutual Small Cap Opps R5 | |||
| NZDGBP | 0.43 | 0.00 | +0.01% |
| New Zealand Dollar - United Kingdom Pound | |||
| JFNIX | 85.02 | -0.19 | -0.22% |
| Janus Henderson Global Life Sciences I | |||